. A nurse is preparing to administer filgrastim 5 mcg/kg/day subcutaneous to a client who weighs 143 lb. How many mcg should the nurse administer per day? (Round the answer to the nearest whole number. Use a leading zero if it applies. Do not use a trailing zero.) _mcg

1. A) Extravasation: Extravasation, or the leaking of IV medication into surrounding tissues, is a potential complication of IV therapy. However, it does not indicate a need to increase the rate of dopamine infusion. Instead, the priority is to stop the infusion, assess the site for damage, and provide appropriate interventions to minimize tissue injury.

   B) Hypotension: Hypotension, or low blood pressure, is a common indication for administering dopamine in septic shock to improve cardiac output and increase blood pressure. If the client's blood pressure remains low despite the’current rate of dopamine infusion, it may be necessary to increase the infusion rate to achieve the desired therapeutic effect and improve perfusion to vital organs. Therefore, hypotension is the correct finding that indicates the need to increase the rate of infusion.

   C) Headache: While headache can occur as a side effect of dopamine infusion, it is not typically an indication to increase the infusion rate. Headache may warrant further assessment and management, but it does not directly correlate with the need for a higher dose of dopamine.

   D) Chest pain: Chest pain may occur as a side effect of dopamine infusion or could be indicative of other cardiac or pulmonary issues. However, like headache, it is not a specific indicator for increasing the rate of dopamine infusion. Further assessment and appropriate interventions are needed to address chest pain, but it does not directly relate to the need for a higher infusion rate of dopamine.
   

A) Instruct the ’lient that their central line dressing must be changed every 24 hr: While it's essential to maintain proper hygiene a’d care for a central line to prevent infection, changing the dressing every 24 hours may not be necessary. The frequency of dressing changes depends on institutional policies and the client's condition. Providing accurate informat’on about dressing changes based on specific guidelines is important for the client's safety and the prevention of central l’ne-related infections.

B) Instruct the client to weigh themselves daily and record their weight: This is the correct instruction. Monitoring daily weight allows for the assessment of fluid status and the effectiveness of TPN therapy. Weight gain or loss can indicate fluid retention or depletion, respectively, which may necessitate adjustments to the TPN prescription. Recording daily weights provides valuable data for healthcare providers to evaluate the client's response to TPN and make appropriate m’difications to the treatment plan.

C) Instruct the client that one container of TPN may infuse for up to 72 hr: The duration of TPN administration varies depending on factors such as the client's nutritional needs, medical condition, ’nd the stability of the TPN solution. While some TPN solutions may be stable for up to 24-48 hours, infusing for 72 hours could increase the risk of contamination and compromise the integrity of the solution, leading to adverse effects. Providing accurate information about the duration of TPN infusion based on the specific prescription ensures the client's safety and the efficacy of therapy.

D’ Instruct the client to speed up the rate of their TPN infusion if it falls behind schedule: Altering the rate of TPN infusion without healthcare provider guidance can lead to complications such as hyperglycemia, electrolyte imbalances, or fluid overload. TPN infusion rates are carefully prescribed based on the client's nutritional needs and metabolic status’ If the infusion falls behind schedule, it's essential for the client to contact th’ir healthcare provider for guidance on adjusting the infusion rate or managing any potential issues.